FRANKLIN RESOURCES INC

Position in BEAM — Beam Therapeutics Inc.

CIK 38777 San Mateo, CA

Position in BEAM

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,043,567

+$483,873 QoQ

Shares Held

30,407

+29.5% QoQ

Ownership

0.029%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#108

of 274 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 96% Shared 0% None 4%

Healthcare · as of Jun 30, 2026

FRANKLIN RESOURCES INC holds $9,179,114,031 across 176 Biotechnology names. BEAM ranks #133 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	2,771,839	$1,728,352,485
2	VRTX	Vertex Pharmaceuticals Inc / Ma	3,347,253	$1,662,680,977
3	ASND	Ascendis Pharma A/S	1,862,503	$496,766,798
4	JAZZ	Jazz Pharmaceuticals plc	2,040,250	$491,639,040
5	RVMD	Revolution Medicines, Inc.	1,488,394	$278,746,426
6	INSM	INSMED Inc	2,273,222	$242,370,927
7	LGND	Ligand Pharmaceuticals Inc	752,044	$237,713,585
8	ARGX	Argenx SE	224,930	$208,683,303

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,043,567	30,407	+29.5%	Shares	Defined	2026-08-13
2026-03-31	$559,694	23,487	+7.0%	Shares	Defined	2026-05-13
2025-12-31	$608,398	21,948	+2.6%	Shares	Defined	2026-02-11
2025-09-30	$518,939	21,382	+12.0%	Shares	Defined	2025-11-13
2025-06-30	$324,855	19,098	-7.2%	Shares	Defined	2025-08-12
2025-03-31	$401,789	20,573	-3.7%	Shares	Defined	2025-05-13
2024-12-31	$529,553	21,353	+42.0%	Shares	Defined	2025-02-12
2024-09-30	$368,430	15,038	+195.9%	Shares	Defined	2024-11-27
2022-03-31	$291,198	5,082	-27.3%	Shares	Defined	2022-05-13
2021-12-31	$557,032	6,990	+2.7%	Shares	Defined	2022-02-11
2021-09-30	$592,276	6,807	+100.8%	Shares	Defined	2021-11-12
2021-06-30	$436,325	3,390	+31.8%	Shares	Defined	2021-08-13
2021-03-31	$205,862	2,572	-99.1%	Shares	Defined	2021-05-13
2020-03-31	$5,409,162	300,509	—	Shares	Defined	2020-05-13
No filing history on record for this holder in this stock.